Abstract:Background—Heterozygous SCN5A mutations have been associated with varied arrhythmia phenotypes; phenotype severity may range from asymptomatic ECG changes (mild phenotype) to symptomatic arrhythmias resulting in syncope, cardiac arrest and sudden cardiac death (severe phenotype) even among family members carrying the same mutation. Risk-stratification schemes for SCN5A mutation carriers remain uncertain. Objective—We used a family based approach to determine the role of SCN5A promoter variants and DNA methylation in predicting phenotype severity in a kindred with loss-of-function SCN5A mutation. Methods—In a large kindred with a heterozygous SCN5A loss-of-function mutation (1936delC, Q646RfsX5; 22 mutation carriers), we sought SCN5A promoter variants. In addition, we assessed SCN5A and genome-wide DNA methylation profiles on genomic DNA derived from blood (Illumina Human Methylation27 BeadChip). Results—During systematic survey of 2.8kb SCN5A promoter region, we identified two SNPs in complete linkage disequilibrium (rs41310749 and rs41310239). These promoter variants were significantly associated with disease severity (mild vs. severe phenotype) (p=0.0007), as all three patients with severe phenotype carried the two-SNP variant on both mutant and wild-type alleles. Analysis did not support a role for methylation of SCN5A related genes. © 2012 The Heart Rhythm Society. Published by Elsevier Inc. All rights reserved. Correspondence to D. Woodrow Benson, MD, PhD, Division of Cardiology, ML7042, Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, Ohio 45229-3039, USA. Fax: (513) 636-2410; Phone: (513) 636-7716; woody.benson@cchmc.org. No authors declare any conflict of interest. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. NIH Public Access Author Manuscript Heart Rhythm. Author manuscript; available in PMC 2013 July 01. Published in final edited form as: Heart Rhythm. 2012 July ; 9(7): 1090–1096. doi:10.1016/j.hrthm.2012.02.023. N IH PA Athor M anscript N IH PA Athor M anscript N IH PA Athor M anscript Conclusion—These family-based genetic findings suggest that the presence of specific promoter variants increase the risk of a severe phenotype in heterozygous carriers of an SCN5A loss-offunction mutation.

Exome Sequencing Identifies a Novel LMNA Splice-Site Mutation and Multigenic Heterozygosity of Potential Modifiers in a Family with Sick Sinus Syndrome, Dilated Cardiomyopathy, and Sudden Cardiac Death

Identification of a Novel LMNA Mutation in a Family with Dilated Cardiomyopathy and Sinus Bradycardia

Whole Genome Sequencing Identifies a Deletion Mutation in the Unknown-Functional KCNG2 from Familial Sick Sinus Syndrome.

Identification of a LMNA (c.646c > T) Variant by Whole-Exome Sequencing in Combination with a Dilated Cardiomyopathy (DCM) Related Gene Filter in a Family with Familiar DCM

Whole-exome Sequencing to Identify a Novel LMNA Gene Mutation Associated with Inherited Cardiac Conduction Disease.

Identification and Functional Characterization of a Novel CACNA1C -Mediated Cardiac Disorder Characterized by Prolonged QT Intervals with Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death

A Novel Splice Mutation of HERG in a Chinese Family with Long QT Syndrome.

Genetic variants in SCN 5 A promoter are associated with arrhythmia phenotype severity in patients with heterozygous loss of function mutation : SCN 5 A promoter variants and phenotype severity

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Genetic insight into sick sinus syndrome

Next-generation Sequencing Identified Novel Desmoplakin Frame-Shift Variant in Patients with Arrhythmogenic Cardiomyopathy

Identification of a Likely Pathogenic Structural Variation in the LAMA1 Gene by Bionano Optical Mapping.

Whole-Exome Sequencing Identifies Y1495x of Scn5a to Be Associated with Familial Conduction Disease and Sudden Death

Characterization of cardiac involvement in patients with LMNA splice-site mutation–related dilated cardiomyopathy and sudden cardiac death

Young and Early‐onset Dilated Cardiomyopathy with Malignant Ventricular Arrhythmia and Sudden Cardiac Death Induced by the Heterozygous LDB3, MYH6, and SYNE1 Missense Mutations

Digenic Heterozygous Mutations of KCNH2 and SCN5A Induced Young and Early‐onset Long QT Syndrome and Sinoatrial Node Dysfunction

Genetic Mutation of Familial Dilated Cardiomyopathy Based on Next‑generation Semiconductor Sequencing.

E0020 Compound Heterozygous Novel Splicing Mutation D202sp and Missence Mutation G272D on KCNQ1 Caused Jervel and Lange-Nielsen Syndrome in a Chinese Family

Next-generation sequencing identifies pathogenic and modifier mutations in a consanguineous Chinese family with hypertrophic cardiomyopathy

Next-generation sequencing identifies a novel heterozygous I229T mutation on LMNA associated with familial cardiac conduction disease.

A Common SCN5A Polymorphism Attenuates a Severe Cardiac Phenotype Caused by a Nonsense SCN5A Mutation in a Chinese Family with an Inherited Cardiac Conduction Defect